Clinical Trial Update: A Study to Understand How a New, Unlicensed Drug Works, Compared With a Placebo, Against BK Virus in Patients Who Have Had a Kidney Transplant. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate an unlicensed BK virus therapy versus placebo in kidney transplant recipients, with the study listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Polyomavirus Infection

Drugs mentioned

• Unlicensed BK virus therapy

Snippet

Sponsor: AiCuris Anti-infective Cures AG | Conditions: BK Virus Infection | Phase 2 | Status: NOT_YET_RECRUITING